Estados Unidos · Bolsa y Finanzas · Yahoo Finance

Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes

Publicado por Yahoo Finance · Estados Unidos hace 14 h

SAN CARLOS, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: PCVX), a clinical-stage vaccine innovation company, announced today the pricing of concurrent underwritten public…

Leer el artículo completo en Yahoo Finance Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finance.yahoo.com)

Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes

También te puede interesar

How Trump’s Tariff War With Canada Ensnared the Can-Am Spyder

Enliven, FDA agree on phase 3 trial design for relcobatinib for chronic myeloid leukemia

Trump set to talk to Russia's Putin 'very soon' about plague-related death in Siberia

Bitcoin.de trading remains halted as German regulator rejects MiCA application

Everything we know about the suspected plague case in Russia so far

Former CIA official with Top Secret clearance admits to $194 million fraud, including 298 gold bars and four luxury South Florida properties

Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes

Compartir

También te puede interesar

How Trump’s Tariff War With Canada Ensnared the Can-Am Spyder

Enliven, FDA agree on phase 3 trial design for relcobatinib for chronic myeloid leukemia

Trump set to talk to Russia's Putin 'very soon' about plague-related death in Siberia

Bitcoin.de trading remains halted as German regulator rejects MiCA application

Everything we know about the suspected plague case in Russia so far

Former CIA official with Top Secret clearance admits to $194 million fraud, including 298 gold bars and four luxury South Florida properties